Evidence map›Paper›PMID 25526311›Full record

ArticleImmunity2014

Dysfunctional HIV-specific CD8+ T cell proliferation is associated with increased caspase-8 activity and mediated by necroptosis.

Gaurav D Gaiha, Kevin J McKim, Matthew Woods, Thomas Pertel, Janine Rohrbach, Natasha Barteneva, Christopher R Chin, Dongfang Liu, Damien Z Soghoian, Kevin Cesa and 9 more

Open access · bronzeAbstract read
In one paragraph

Article in Immunity, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 74 citations in OpenAlex.

  1. NK-like and networked CD8bioRxiv : the preprint server for biology · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Memory stem CD8Frontiers in cellular and infection microbiology · 2024
    Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. An expanded population of CD8Frontiers in cell and developmental biology · 2022
    Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 6 institutions in 1 country.

Gaurav D GaihaRagon Institute of MGH, Cambridge, MA 02139, USA.
Kevin J McKimRagon Institute of MGH, Cambridge, MA 02139, USA.
Matthew WoodsRagon Institute of MGH, Cambridge, MA 02139, USA.
Thomas PertelCenter for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA 02115, USA.
Janine RohrbachRagon Institute of MGH, Cambridge, MA 02139, USA.
Natasha BartenevaProgram in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA 02115, USA.
Christopher R ChinRagon Institute of MGH, Cambridge, MA 02139, USA; Department of Microbiology and Physiological Systems (MaPS), University of Massachusetts Medical School, Worcester, MA 01655, USA.
Dongfang LiuCenter for Human Immunobiology, Texas Children's Hospital, Baylor College of Medicine, Houston, TX 77030, USA.
Damien Z SoghoianRagon Institute of MGH, Cambridge, MA 02139, USA.
Kevin CesaRagon Institute of MGH, Cambridge, MA 02139, USA.
Shannon WiltonRagon Institute of MGH, Cambridge, MA 02139, USA.
Michael T WaringRagon Institute of MGH, Cambridge, MA 02139, USA; Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA.
Adam ChicoineRagon Institute of MGH, Cambridge, MA 02139, USA.
Travis DoeringHofstra North Shore-LIJ School of Medicine, Hempstead, NY 11549, USA.
E John WherryDepartment of Microbiology and Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Daniel E KaufmannRagon Institute of MGH, Cambridge, MA 02139, USA; Centre de Recherche du Centre Hospitalier de l'Universite de Montreal (CRCHUM), Montreal, QC H2X 0A9, Canada.
Mathias LichterfeldRagon Institute of MGH, Cambridge, MA 02139, USA; Infectious Disease Division, Massachusetts General Hospital, Boston, MA 02114, USA.
Abraham L BrassRagon Institute of MGH, Cambridge, MA 02139, USA; Department of Microbiology and Physiological Systems (MaPS), University of Massachusetts Medical School, Worcester, MA 01655, USA.
Bruce D WalkerRagon Institute of MGH, Cambridge, MA 02139, USA; Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA; Infectious Disease Division, Massachusetts General Hospital, Boston, MA 02114, USA. Electronic address: bwalker@partners.org.
Ragon Institute of MGH, MIT and Harvard · USBoston Children's Hospital · USBrigham and Women's Hospital · USHofstra University · USTexas Children's Hospital · USUniversity of Pennsylvania · US

Funding

The impact of HIV viral diversity and cellular immunity on HIV pathogenesisP30AI060354 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI ROBERT A. PARKER · 2004 to 2026
$94.4M
Virology CoreU19AI082630 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI RAYMOND T CHUNG, GEORG Michael LAUER · 2009 to 2026
$48.1M
Pilot & Feasibility ProgramP30DK043351 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI RAYMOND T CHUNG · 1991 to 2026
$35.3M
Regulation of protective immunity following enteric viral infectionU01AI095608 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI ARTIS, DAVID, SONNENBERG, GREGORY F · 2011 to 2025
$11.0M
P3: Chemokine-Mediated T Cell Trafficking in HIV Transmission and Immune ResponseP01AI112521 · NIAID · HARVARD MEDICAL SCHOOL · PI LUSTER, ANDREW · 2014 to 2018
$9.8M
INHIBITION OF HIV1 REPLICATION BY CYTOTOXIC LYMPHOCYTESR01AI030914 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI WALKER, BRUCE D · 1991 to 2013
$4.2M
Cellular and transcriptional control of exhausted CD8 T cells lineage dynamicsR01AI105343 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI WHERRY, E. JOHN · 2014 to 2017
$1.6M
Howard Hughes Medical InstituteNIAID NIH HHS AI082630NIAID NIH HHS AI095608NIAID NIH HHS AI105343NIAID NIH HHS AI112521NIAID NIH HHS AI30914NIAID NIH HHS HHSN266200500030CNIAID NIH HHS P01 AI112521NIAID NIH HHS P30 AI060354NIAID NIH HHS R01 AI030914NIAID NIH HHS R01 AI105343NIAID NIH HHS U01 AI095608NIAID NIH HHS U19 AI082630NIDDK NIH HHS P30 DK043351
6 · The paper itself

Abstract

Decreased HIV-specific CD8(+) T cell proliferation is a hallmark of chronic infection, but the mechanisms of decline are unclear. We analyzed gene expression profiles from antigen-stimulated HIV-specific CD8(+) T cells from patients with controlled and uncontrolled infection and identified caspase-8 as a correlate of dysfunctional CD8(+) T cell proliferation. Caspase-8 activity was upregulated in HIV-specific CD8(+) T cells from progressors and correlated positively with disease progression and programmed cell death-1 (PD-1) expression, but negatively with proliferation. In addition, progressor cells displayed a decreased ability to upregulate membrane-associated caspase-8 activity and increased necrotic cell death following antigenic stimulation, implicating the programmed cell death pathway necroptosis. In vitro necroptosis blockade rescued HIV-specific CD8(+) T cell proliferation in progressors, as did silencing of necroptosis mediator RIPK3. Thus, chronic stimulation leading to upregulated caspase-8 activity contributes to dysfunctional HIV-specific CD8(+) T cell proliferation through activation of necroptosis and increased cell death.

Indexed as

Caspase 8CD8-Positive T-LymphocytesCell ProliferationCells, CulturedDisease ProgressionEnzyme ActivationGene Expression RegulationHIVHIV Core Protein p24HIV InfectionsHumansNecrosisPeptide FragmentsProgrammed Cell Death 1 ReceptorReceptor-Interacting Protein Serine-Threonine KinasesRNA, Small InterferingCaspase 8HIV Core Protein p24PDCD1 protein, humanPeptide FragmentsProgrammed Cell Death 1 ReceptorReceptor-Interacting Protein Serine-Threonine KinasesRIPK3 protein, humanRNA, Small Interfering

Identifiers

PMID25526311
PMCPMC4312487
OpenAlexW2077097921

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.